Related Experiment Videos
Transforming growth factor-alpha antisense vectors can inhibit glioma cell growth
1Department of Neuro-oncology, The University of Texas, M.D. Anderson Cancer Center, Houston 77030, USA.
Abstract:
The effects of transforming growth factor-alpha (TGF-alpha) on cell growth were studied in human glioma U251 cells transfected with antisense TGF-alpha vectors (pcDNAI.neo). Several antisense clones showed a marked decrease in growth rate in serum-free medium but not in medium containing 10% FBS, compared with those of parental cells and clones from sense or vector transfectants. Antisense clones also produced fewer and smaller colonies in anchorage-independent growth assays. Moreover, there was a reduction in TGF-alpha expression in these antisense clones at both the protein and mRNA levels, as determined by enzyme linked immuno-sorbent assay and reverse transcriptase polymerase chain reaction analysis. A U251 clone transfected by TGF-alpha antisense in a different vector (pMT/Ep) also showed a marked suppression in cell growth and TGF-alpha mRNA level. Finally, transfected clones with either vector system, showed decreased tumorigenicity in nude mice. In summary, a strong correlation between the inhibition of glioma cell growth and TGF-alpha expression was obtained from two different plasmid vectors, indicating that the expression of TGF-alpha could be specifically and effectively down-regulated by TGF-alpha antisense vector, which in turn led to growth inhibition. These studies suggests that TGF-alpha plays an essential role in controlling human glioma cell proliferation and may serve as a potential target for treatment of malignant glioma.
Insights
Transforming growth factor-alpha (TGF-alpha) antisense vectors effectively inhibited human glioma cell growth and reduced TGF-alpha expression. This suggests TGF-alpha is crucial for glioma proliferation and a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Transforming growth factor-alpha (TGF-alpha) is implicated in various cancers.
- Understanding its role in human glioma U251 cells is critical for developing targeted therapies.
Purpose of the Study:
- To investigate the effect of down-regulating TGF-alpha expression on human glioma cell proliferation.
- To assess the potential of TGF-alpha as a therapeutic target for malignant glioma.
Main Methods:
- Transfection of human glioma U251 cells with TGF-alpha antisense vectors (pcDNAI.neo and pMT/Ep).
- Assessment of cell growth rates in different media conditions.
- Colony formation assays for anchorage-independent growth.
- Enzyme-linked immunosorbent assay (ELISA) and reverse transcriptase polymerase chain reaction (RT-PCR) to measure TGF-alpha protein and mRNA levels.
- Tumorigenicity studies in nude mice.
Main Results:
- Antisense TGF-alpha transfectants exhibited significantly reduced growth rates, colony formation, and TGF-alpha expression (both protein and mRNA) compared to controls.
- Suppression of TGF-alpha was observed with two different vector systems.
- Transfected clones demonstrated decreased tumorigenicity in vivo.
- A strong correlation was found between reduced TGF-alpha expression and inhibited glioma cell growth.
Conclusions:
- TGF-alpha plays an essential role in controlling human glioma cell proliferation.
- TGF-alpha antisense vectors can effectively down-regulate TGF-alpha expression, leading to growth inhibition.
- Targeting TGF-alpha represents a promising therapeutic strategy for malignant glioma.